Product Description
please call me ,to know more
AI Product Description
*The following content is generated by AI and is for reference only.
Mogroside IV, chemically designated as 13β-hydroxy-24-nor-dammar-20(22)-ene-3β,12β,25-triol-3-O-α-L-rhamnopyranosyl-(1→2)-[α-L-rhamnopyranosyl-(1→6)]-β-D-glucopyranoside, is a potent natural sweetener and bioactive triterpene glycoside isolated primarily from the fruit of *Siraitia grosvenorii*, commonly known as monk fruit. With the molecular formula C39H64O12 and a CAS registry number of 18713-43-0, this compound represents one of the major mogrosides responsible for the intense sweetness profile of the plant. It exhibits a sweetness potency approximately 100 to 250 times that of sucrose while contributing zero calories, making it an ideal alternative sweetener for health-conscious consumers and the food and beverage industries seeking to reduce sugar intake without compromising taste.
Beyond its functional role as a non-caloric sweetener, Mogroside IV possesses significant pharmacological properties. Extensive research indicates its strong antioxidant activity, which helps neutralize free radicals and reduces oxidative stress in biological systems. Furthermore, studies suggest potential anti-inflammatory effects and benefits for respiratory health, aligning with traditional uses of monk fruit in treating coughs and sore throats. The compound demonstrates high stability under various processing conditions, including heat and pH variations, ensuring its efficacy in diverse food formulations ranging from beverages and dairy products to confectionery and dietary supplements. Its safety profile is well-established, having been generally recognized as safe (GRAS) by regulatory bodies in several countries, facilitating its widespread adoption globally. As the demand for clean-label, natural ingredients continues to rise, Mogroside IV stands out not only for its exceptional sweetness but also for its dual function as a flavor enhancer and a functional health ingredient. This unique combination of sensory attributes and therapeutic potential positions Mogroside IV as a cornerstone in the development of next-generation low-calorie foods and nutraceuticals aimed at combating lifestyle-related diseases such as obesity and diabetes.